Eye 39 , 20902095 (2025)
With the right support, like regular check-ins, expert guidance, and real-time help, patients are more likely to feel confident, informed, and in control
Clinicians might consider preferring GLP-1 receptor agonists over other diabetes treatments, such as insulin, for patients at high risk of obesity-associated cancers. Wang and colleagues conducted a retrospective cohort study of deidentified electronic health records on the TriNetX platform
Food and Drug Administration-approved medications do, said Liang-Yuan Lin, an Ole Miss doctoral candidate in pharmacy administration who researches compounded drug pharmacies
Supplementing 2,000 to 4,000 IU daily is generally recommended